Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,293.00p

Buy

1,295.00p

arrow-up21.00p (+1.63%)

Prices updated at 02 Apr 2026, 17:20 BST

Prices minimum 15 mins delay

Prices in GBX

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

FTSE All-Share

0.59%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	3,127m	3,349m
	1,415m	1,441m
	612m	633m
	19.57	18.90
	359m	402m
	698m	845m
Sales, General and administrative	568m	566m
Interest expenses	75m	88m
Provision for income taxes	93m	112m
Operating expenses	803m	808m
Income before taxes	455m	519m
Net income available to common shareholders	359m	402m
	1.62	1.82
Net interest income	-80m	-91m
Advertising and promotion	-	-
Net investment income, net	-21m	-11m
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	1.61	1.81
Free cash flow per share	1.8136	0.7599
Book value/share	8.2648	8.563
Debt equity ratio	0.282684	0.574624

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	2,263m	2,643m
Current liabilities	1,978m	1,453m
Total capital	2,917m	4,038m
Total debt	1,306m	1,604m
Total equity	2,310m	2,593m
Total non current liabilities	-	-
Loans	607m	1,445m
Total assets	5,133m	5,671m
Total liabilities	-	-
Cash and cash equivalents	188m	217m
Common stock	220m	220m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	205m	188m
Cash dividends paid	-175m	-185m
	329m	119m
Investments (gains) losses	-381m	-388m
	188m	217m
Net income	-	-
	564m	436m
	-235m	-317m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.